Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank
Status: Recruiting
Location: See all (11) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
The HAMA bank is an initiative aimed at collecting, preparing, and storing biological samples from patients treated for malignant hypertension and included in the HAMA cohort. Conducted under CRB (ISO20387) conditions, this biobank serves as an essential resource for understanding the disease's pathophysiology, as well as for identifying novel biomarkers and therapeutic targets
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• patients included in the HAMA cohort with the following critera :
‣ Malignant hypertension according to the classic definition (Severe hypertension associated with severe hypertensive retinopathy)
⁃ Severe hypertension associated with acute target organ damage due to high blood pressure
Locations
Other Locations
France
CH d'Annecy
RECRUITING
Annecy
CHU de Bordeaux
RECRUITING
Bordeaux
CH de Chalon sur Saône
RECRUITING
Chalon-sur-saône
Hospices Civils de Lyon
NOT_YET_RECRUITING
Lyon
APHP Avicenne
RECRUITING
Paris
Hôpital Européen Georges Pompidou
RECRUITING
Paris
Hôpital Paris Saint Joseph
RECRUITING
Paris
CHU de Strasbourg
RECRUITING
Strasbourg
CHU de Toulouse
RECRUITING
Toulouse
CHRU de Tours
RECRUITING
Tours
CH de Valenciennes
RECRUITING
Valenciennes
Contact Information
Primary
Alice SERIS
alice.seris@ch-pau.fr
0559726997
Time Frame
Start Date: 2026-03-19
Estimated Completion Date: 2036-04-01
Participants
Target number of participants: 1000
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier de PAU